Target intelligence / Profile preview

Stratum corneum cohesion protein

Molecular classification
Other (structural protein), Adhesion molecule
01

Overview

“Stratum corneum cohesion proteins” is not a single molecular target but refers collectively to several structural and adhesion proteins critical for the integrity of the stratum corneum, the outermost layer of the epidermis. Key proteins include corneodesmosin (CDSN), desmocollin 1 (DSC1), and desmoglein 1 (DSG1), which are integral components of *corneodesmosomes*—specialized cell junctions linking adjacent corneocytes and maintaining skin barrier cohesion. Their regulated degradation by specific serine proteases (KLK5, KLK7) enables controlled cell shedding (desquamation). Disruption or abnormal proteolysis of these proteins impairs barrier function and is associated with dermatological diseases, including atopic dermatitis and ichthyosis[1][7][3]. Since “stratum corneum cohesion proteins” does not correspond to a unique, singular target but rather a mixture of molecules, this entry is non-canonical and too general for structured database indexing[1][3][7].

Other names
Corneodesmosin (CDSN)desmocollin 1 (DSC1)desmoglein 1 (DSG1)
02

Mechanism of action

Proteolysis by serine proteases (KLK5, KLK7) leads to degradation of adhesion proteins (e.g., corneodesmosin), reducing cohesion and allowing desquamation[1][7]

03

Biological functions

Skin barrier integritycell-cell adhesiondesquamation (shedding of corneocytes)maintenance of skin homeostasis
04

Disease associations

Skin disorders (particularly atopic dermatitis, ichthyosis, psoriasis, and other barrier function disorders)Other
05

Safety considerations

Disruption can lead to impaired skin barrier, increasing risks of inflammation, infection, and dehydration. Therapies that alter adhesion protein function must avoid excessive skin fragility or impaired desquamation[7]
06

Interacting drugs

None established; topical agents like superbases or protease inhibitors may affect SC cohesion[1][7]
07

Biomarkers

Fragments or altered expression of corneodesmosin and other adhesion proteins may serve as biomarkers for skin barrier integrity and disease status[1][7]

Beyond the preview

Go deeper on Stratum corneum cohesion protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stratum corneum cohesion protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call